Methotrexate for advanced cancer of the breast
โ Scribed by William R. Vogler; Valdir P. Furtado; Charles M. Huguley Jr.
- Publisher
- John Wiley and Sons
- Year
- 1968
- Tongue
- English
- Weight
- 409 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
The modalities used to treat 27 male patients with metastatic breast cancer at Memorial Hospital from 1957-1979 are reviewed. The overall objective orchiectomy response rate was 48% (11123). The median response was 11 months (6-96 months). The median survival in responders was 58 months, whereas the
Recent in vitro and animal tumor studies suggest that sequential methotrexate (MTX) and 5-fluorouracil (5-FU) may be much more tumoricidal than either drug when used alone or in conventional combinations. Seventeen evaluable female patients with advanced carcinoma of the breast were treated with MTX